Literature DB >> 23499676

MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.

Dan Zhong1, Gang Huang, Yan Zhang, Yijun Zeng, Zhizhen Xu, Yuanyin Zhao, Xie He, Fengtian He.   

Abstract

Liver X receptor α (LXRα) plays a critical role in the transcriptional control of lipid metabolism. LXR activation induces the expression of lipogenic genes, which promote hepatic steatosis and steatohepatitis. However, the regulation of LXR is not fully understood. MicroRNAs (miRs) are regarded as important negative regulators of gene expression. In this study, we found that miR-1/miR-206 repressed LXRα-induced accumulation of lipid droplets in hepatocytes. In addition, bioinformatic analysis predicted a same putative target-site for miR-1/miR-206 located within the 3'-untranslated region (3'-UTR) of LXRα mRNA. The reporter assay revealed that miR-1/miR-206 directly targeted the 3'-UTR of LXRα mRNA. Furthermore, miR-1/miR-206 repressed LXRα expression at both mRNA and protein levels, accompanied with the inhibition of expression of LXRα target genes, such as sterol-regulatory element binding protein 1c, fatty acid synthase, carbohydrate responsive element-binding protein and acetyl-CoA carboxylase 1, which are important effectors of LXRα implicated in lipogenesis. Moreover, ectopic expression of LXRα without the 3'-UTR dramatically attenuated the miR-1/miR-206-induced decrease of lipogenic genes and lipid droplet accumulation. Taken together, we for the first time demonstrated that miR-1/miR-206 attenuated LXRα-induced lipogenesis by targeting the 3'-UTR of LXRα mRNA, suggesting that miR-1/miR-206-LXRα pathway may be a novel target for the treatment of lipogenesis-associated diseases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499676     DOI: 10.1016/j.cellsig.2013.03.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

Review 2.  The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication.

Authors:  Wanyu Deng; Mengji Lu
Journal:  Virol Sin       Date:  2016-12-28       Impact factor: 4.327

Review 3.  MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Neurobiol Dis       Date:  2014-06-05       Impact factor: 5.996

Review 4.  microRNAs and HDL life cycle.

Authors:  Alberto Canfrán-Duque; Cristina M Ramírez; Leigh Goedeke; Chin-Sheng Lin; Carlos Fernández-Hernando
Journal:  Cardiovasc Res       Date:  2014-06-03       Impact factor: 10.787

Review 5.  MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.

Authors:  Hyejin Yoon; Luis F Flores; Jungsu Kim
Journal:  Biochim Biophys Acta       Date:  2016-05-04

6.  MicroRNA-206 regulates surfactant secretion by targeting VAMP-2.

Authors:  Honghao Zhang; Yujie Guo; Amarjit Mishra; Deming Gou; Narendranath Reddy Chintagari; Lin Liu
Journal:  FEBS Lett       Date:  2014-12-04       Impact factor: 4.124

Review 7.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

Review 8.  MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.

Authors:  Juan F Aranda; Julio Madrigal-Matute; Noemi Rotllan; Carlos Fernández-Hernando
Journal:  Free Radic Biol Med       Date:  2013-07-17       Impact factor: 7.376

9.  Lipogenesis mitigates dysregulated sarcoplasmic reticulum calcium uptake in muscular dystrophy.

Authors:  Christopher W Paran; Kai Zou; Patrick J Ferrara; Haowei Song; John Turk; Katsuhiko Funai
Journal:  Biochim Biophys Acta       Date:  2015-09-08

Review 10.  MicroRNAs in the onset and development of cardiovascular disease.

Authors:  Kasey C Vickers; Kerry-Anne Rye; Fatiha Tabet
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.